Retrospective Evaluation of <i>BCR::ABL</i> Kinase Domain Mutation Profiles and Treatment Outcomes in Patients with Chronic Myeloid Leukemia to Confirm Clinical Relevance of in Vitro Sensitivity-Based Treatment Switch: Real-World ExperienceMaría Agustina Perusini, Dennis Kim, Filza Gul et al.|Blood|2024Cited by 0